90 years of Klöber: A success story “Made am Bodensee”

12.11.2025 10:00:00 CET | news aktuell GmbH | Press Release

Share

Owingen, 12.11.2025: How much courage does it take to start up a furniture company – as a 25-year-old woman, in 1935, in a male-dominated industry? A lot! Back then, Margarete Klöber just did it. The qualified foreign correspondent wanted to ensure healthier sitting and came up with the Polstergleich, one of the first ergonomic office chairs in Germany. The model, with its sprung construction and adjustable backrest, became a success, and Margarete Klöber a pioneer of modern seating.

Homage to the beginnings

Nine decades later, the company from Owingen in the Bodensee region is celebrating this legacy with a new design that both reflects the past and represents a fresh start: the CoMeet C35. The swivel chair, designed by Jörg Bernauer, is a tribute to the legendary Polstergleich. Its distinctive wooden starbase and minimalist rotating spindle combine homeliness with function, while the seat shell made of PET felt or recycled polypropylene brings the theme of sustainability into the present.

A new chapter in mesh backrest design

The Connex model also received a new look for Klöber’s 90th anniversary. Conventional mesh fabrics are often too transparent, feel physically cool and create unnecessary waste in production due to offcuts. Furthermore, there is often a lack of choice with regard to colour – especially if the back and seat are meant to have a uniform look. Connex Mesh Melange is our answer to this: the fabric is knitted to fit without offcuts. It is breathable, elastic and offers noticeable comfort in every sitting position.

The art of sitting

“Each of our products follows the philosophy of optimally combining sustainability and innovation,” says CEO Thomas Möller. This interplay continues to shape Klöber to this day – from material selection and durable construction to a clear, timeless design language. The chairs occupy the space with the same unquestioned status as Margarete Klöber’s Polstergleich did back in 1935.

Contacts

Klöber Press Office
Bernadette Trepte
kloeber@real-communications.com
+49 7551- 838-0

Images

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye